• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Christopher Boerner

CDF24
Pharma

Big Pharma CEOs offer China renewed interest, policy advice

Intellectual property protections and an optimized drug reimbursement system were on top of the CEOs' minds during the China Development Forum.
Angus Liu Mar 26, 2024 11:46am
Caforio

BMS scouts for M&A deals amid multiple new launches: CEO

Apr 27, 2023 1:13pm
Bristol Myers Squibb CEO Giovanni Caforio debuts new brand

BMS' Caforio to hand CEO baton to commercial chief Boerner

Apr 26, 2023 5:03pm
BMS

BMS touts 'diversified' new launches, M&A as 'top priority'

Jan 9, 2023 3:20pm
abecma

Bristol Myers hits Abecma CAR-T manufacturing bottleneck

Jul 28, 2021 10:48am
Bristol Myers Squibb CEO Giovanni Caforio debuts new brand

Analysts to BMS: Can I-O hit Opdivo really return to growth?

Aug 6, 2020 10:44am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings